Quarterly report pursuant to Section 13 or 15(d)

9. Segment and Geographic Information

v2.4.0.6
9. Segment and Geographic Information
 9 Months Ended
Dec. 31, 2012
Segment And Geographic Information  
Note 9. Segment and Geographic Information

The Company generates revenues from wound care products which are sold into the human and animal health care markets and the Company also generates revenues from laboratory testing services which are provided to medical device manufacturers. The Company operates a single segment business which consists of three geographical sales territories as follows (in thousands):

 

    Three Months     Nine Months  
    Ended     Ended  
    December 31,     December 31,  
    2012     2011     2012     2011  
U.S.   $ 1,653     $ 1,005     $ 5,584     $ 3,291  
Mexico     1,356       1,168       4,596       3,852  
Europe and Other     348       424       1,257       1,554  
    $ 3,357     $ 2,597     $ 11,437     $ 8,697  

 

For the three months ended December 31, 2012 and 2011, the Company received licensing revenues of $702,000 and $94,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned. For the nine months ended December 31, 2012 and 2011, the Company received licensing revenues of $1,125,000 and $318,000, respectively. Such revenues are included in the Company’s calculation of product revenues and are reflected in the table above under the respective geographic region where such licensing revenues were earned.

 

The Company’s service revenues amounted to $183,000 and $193,000 for the three months ended December 31, 2012 and 2011, respectively, and the Company’s service revenues amounted to $680,000 and $696,000 for the nine months ended December 31, 2012 and 2011, respectively.